Improving Lives for Less
*New data* The 2016 Generic Drug Savings and Access in the U.S. report shows that generic pharmaceuticals saved the U.S. health system $227 billion in 2015. This year’s report features state-by-state savings, therapy area and public program savings and more. Data compiled by the QuintilesIMS Institute. Learn more >
Value and Quality
The Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA), works to ensure a positive environment for patient access to biosimilar medicines.
Click here for more information.
2015 Annual Report
The 2015 Annual Report is now available. GPhA furthers the industry’s goal to improve the lives of consumers by providing timely access to high quality, affordable medicine. Together, we continue to drive value and quality for patients. Learn More >